BriMindInvest Logo

GEHC (GEHC) Stock Analysis 2026

Healthcare
$61.99as of 2026-07-23

BriMind AI Score

Proprietary
31
Weak
Price CAGR
1.5%
1Y Return
-17.0%
Analyst Upside
+25.8%
Rev Growth
7.4%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$60.01-3.2% potential
Bear Case
$39.15
Bull Case
$89.90
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

GEHC Revenue & Profitability Breakdown

This chart shows how GEHC's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$20.98B
Cost of Revenue
-$12.77B
Gross Profit
$8.21B39.1% margin
Operating Expenses
-$5.89B
Operating Income
$2.33B11.1% margin
Tax & Other
-$417.3M
Net Income
$1.91B9.1% margin
Gross Margin
39.1%
Operating Margin
11.1%
Net Margin
9.1%

Key Financial Metrics

A snapshot of the company's valuation, growth, profitability, and financial health. Key things to look at: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business — companies with strong FCF can buy back shares, pay dividends, or invest; Debt/Equity shows how leveraged the company is (high debt can be risky); Return on Equity tells you how efficiently the company generates profit from shareholders' money.

Market Cap
$28.69B
P/E (Trailing)
15.12
P/E (Forward)
11.76
Revenue
$20.98B
Revenue Growth
7.4%
Earnings Growth
-30.9%
Gross Margin
39.1%
Operating Margin
11.1%
Net Margin
9.1%
Return on Equity
19.5%
Return on Assets
5.2%
Free Cash Flow
$1.48B
Debt / Equity
97.06
Current Ratio
1.22
Quick Ratio
0.81
Beta
0.84
Dividend Yield
0.2%
Payout Ratio
4.2%
Book Value / Share
$23.45

Wall Street Analyst Consensus

Professional analysts at investment banks set 12-month price targets after researching the company's earnings, competitive position, and industry trends. Strong Buy / Buy means the majority expect meaningful upside. Hold means analysts see fair value near the current price — not a sell signal, but limited near-term upside expected. The mean target is the average of all analyst price targets; the range shows where the most optimistic and most cautious analysts stand.

Mean Target$79.33+28.0% upside

Unlock the Full GEHC Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
← Back to Home · Browse All Stock Analysis